Alerts will be sent to your verified email
Verify EmailHESTERBIO
Hester Biosciences
|
Bajaj Healthcare
|
Themis Medicare
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.91 % | 1.2 % | 3.26 % |
Financials
|
|||
5 yr Average ROE
|
10.99 % | 9.93 % | 15.48 % |
5yr average Equity Multiplier
|
2.14 | 2.26 | 1.56 |
5yr Average Asset Turnover Ratio
|
0.46 | 0.95 | 0.71 |
5yr Avg Net Profit Margin
|
11.57 % | 3.65 % | 13.75 % |
Price to Book
|
5.44 | 2.87 | 2.96 |
P/E
|
45.43 | 28.45 | 0.0 |
5yr Avg Cash Conversion Cycle
|
60.38 Days | 15.4 Days | 62.99 Days |
Inventory Days
|
100.79 Days | 51.52 Days | 69.58 Days |
Days Receivable
|
89.02 Days | 72.17 Days | 159.79 Days |
Days Payable
|
127.62 Days | 83.01 Days | 137.27 Days |
5yr Average Interest Coverage Ratio
|
6.96 | 7.11 | 7.27 |
5yr Avg ROCE
|
11.14 % | 24.2 % | 17.31 % |
5yr Avg Operating Profit Margin
|
22.71 % | 16.67 % | 18.07 % |
5 yr average Debt to Equity
|
0.75 | 0.86 | 0.28 |
5yr CAGR Net Profit
|
-4.4 % | n/a | -3.53 % |
5yr Average Return on Assets
|
5.28 % | 5.32 % | 9.9 % |
Shareholdings
|
|||
Promoter Holding
|
53.73 % | 59.19 % | 67.15 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 2.43 % |
Change in Promoter Holding (3 Yrs)
|
0.0 | -8.11 % | -0.03 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 1.66 % | 0.0 |
Hester Biosciences
|
Bajaj Healthcare
|
Themis Medicare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Capex
|
Capex
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|